Locating folds of the in-register parallel β-sheet of the Sup35p prion domain infectious amyloid

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 43, 2014, Pages E4615-E4622

  Gorkovskiy, Anton ^a   Thurber, Kent R ^a   Tycko, Robert ^a   Wickner, Reed B ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Amyloid; Dipolar recoupling; Solid state NMR; Sup35; PSI+ prion

Indexed keywords

AMYLOID; BACTERIAL PROTEIN; PROTEIN SUP35P; UNCLASSIFIED DRUG; MUTANT PROTEIN; PRION; SACCHAROMYCES CEREVISIAE PROTEIN; SUP35 PROTEIN, S CEREVISIAE; TRANSLATION TERMINATION FACTOR;

ARTICLE; BETA SHEET; GENE SEQUENCE; NONHUMAN; PRION; PROTEIN DOMAIN; SUP35 GENE; VIRUS GENE; AMINO ACID SEQUENCE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMISTRY; GENETIC TRANSFECTION; METABOLISM; MOLECULAR GENETICS; PROTEIN SECONDARY STRUCTURE; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; AMYLOID; CARBON-13 MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PEPTIDE TERMINATION FACTORS; PRIONS; PROTEIN STRUCTURE, SECONDARY; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSFECTION;

EID: 84908307977     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1417974111     Document Type: Article

References (64)

1. Wickner RB, et al. (2013) Amyloids and yeast prion biology. Biochemistry 52(9):1514-1527.
2. Benzinger TL, et al. (1998) Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register. Proc Natl Acad Sci USA 95(23):13407-13412.
3. Paravastu AK, Leapman RD, Yau WM, Tycko R (2008) Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils. Proc Natl Acad Sci USA 105(47):18349-18354.
4. Petkova AT, Yau WM, Tycko R (2006) Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry 45(2):498-512.
5. Tycko R (2011) Solid-state NMR studies of amyloid fibril structure. Annu Rev Phys Chem 62:279-299.
6. Petkova AT, et al. (2005) Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils. Science 307(5707):262-265.
7. Chen B, Thurber KR, Shewmaker F, Wickner RB, Tycko R (2009) Measurement of amyloid fibril mass-per-length by tilted-beam transmission electron microscopy. Proc Natl Acad Sci USA 106(34):14339-14344.
8. Meinhardt J, Sachse C, Hortschansky P, Grigorieff N, Fändrich M (2009) Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. J Mol Biol 386(3):869-877.
9. Bertini I, Gonnelli L, Luchinat C, Mao J, Nesi A (2011) A new structural model of Aβ40 fibrils. J Am Chem Soc 133(40):16013-16022.
10. Lopez del Amo JM, et al. (2012) An asymmetric dimer as the basic subunit in Alzheimer's disease amyloid β fibrils. Angew Chem Int Ed Engl 51(25):6136-6139.
11. Lu JX, et al. (2013) Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue. Cell 154(6):1257-1268.
12. Watts JC, et al. (2014) Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients. Proc Natl Acad Sci USA 111(28):10323-10328.
13. Luca S, Yau W-M, Leapman R, Tycko R (2007) Peptide conformation and supramolecular organization in amylin fibrils: Constraints from solid-state NMR. Biochemistry 46(47):13505-13522.
14. Margittai M, Langen R (2008) Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: Molecular insights from electron paramagnetic resonance spectroscopy. Q Rev Biophys 41(3-4):265-297.
15. Debelouchina GT, et al. (2013) Higher order amyloid fibril structure by MAS NMR and DNP spectroscopy. J Am Chem Soc 135(51):19237-19247.
16. Serag AA, Altenbach C, GingeryM, Hubbell WL, Yeates TO (2002) Arrangement of subunits and ordering of beta-strands in an amyloid sheet. Nat Struct Biol 9(10):734-739.
17. Bateman DA, Tycko R, Wickner RB (2011) Experimentally derived structural constraints for amyloid fibrils of wild-type transthyretin. Biophys J 101(10):2485-2492.
18. Coustou V, Deleu C, Saupe S, Begueret J (1997) The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog. Proc Natl Acad Sci USA 94(18):9773-9778.
19. Saupe SJ (2011) The [Het-s] prion of Podospora anserina and its role in heterokaryon incompatibility. Semin Cell Dev Biol 22(5):460-468.
20. Ritter C, et al. (2005) Correlation of structural elements and infectivity of the HET-s prion. Nature 435(7043):844-848.
21. Wasmer C, et al. (2008) Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core. Science 319(5869):1523-1526.
22. Wickner RB (1994) [URE3] as an altered URE2 protein: Evidence for a prion analog in Saccharomyces cerevisiae. Science 264(5158):566-569.
23. Derkatch IL, Bradley ME, Hong JY, Liebman SW (2001) Prions affect the appearance of other prions: The story of [PIN(+)]. Cell 106(2):171-182.
24. Ter-Avanesyan MD, Dagkesamanskaya AR, Kushnirov VV, Smirnov VN (1994) The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics 137(3):671-676.
25. Masison DC, Wickner RB (1995) Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science 270(5233):93-95.
26. Paushkin SV, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD (1997) In vitro propagation of the prion-like state of yeast Sup35 protein. Science 277(5324):381-383.
27. King C-Y, et al. (1997) Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc Natl Acad Sci USA 94(13):6618-6622.
28. Glover JR, et al. (1997) Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell 89(5):811-819.
29. Edskes HK, Gray VT, Wickner RB (1999) The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc Natl Acad Sci USA 96(4):1498-1503.
30. TanakaM, Chien P, Naber N, Cooke R, Weissman JS (2004) Conformational variations in an infectious protein determine prion strain differences. Nature 428(6980):323-328.
31. King CY, Diaz-Avalos R (2004) Protein-only transmission of three yeast prion strains. Nature 428(6980):319-323.
32. Brachmann A, Baxa U, Wickner RB (2005) Prion generation in vitro: Amyloid of Ure2p is infectious. EMBO J 24(17):3082-3092.
33. Patel BK, Liebman SW (2007) "Prion-proof" for [PIN+]: Infection with in vitro-made amyloid aggregates of Rnq1p-(132-405) induces [PIN+]. J Mol Biol 365(3):773-782.
34. Baxa U, et al. (2007) Characterization of β-sheet structure in Ure2p1-89 yeast prion fibrils by solid-state nuclear magnetic resonance. Biochemistry 46(45):13149-13162.
35. Kryndushkin DS, Wickner RB, Tycko R (2011) The core of Ure2p prion fibrils is formed by the N-terminal segment in a parallel cross-β structure: Evidence from solid-state NMR. J Mol Biol 409(2):263-277.
36. Ngo S, Gu L, Guo Z (2011) Hierarchical organization in the amyloid core of yeast prion protein Ure2. J Biol Chem 286(34):29691-29699.
37. Bradley ME, Liebman SW (2004) The Sup35 domains required for maintenance of weak, strong or undifferentiated yeast [PSI+] prions. Mol Microbiol 51(6):1649-1659.
38. Bateman DA, Wickner RB (2012) [PSI+] Prion transmission barriers protect Saccharomyces cerevisiae from infection: Intraspecies 'species barriers'. Genetics 190(2):569-579.
39. Toyama BH, Kelly MJ, Gross JD, Weissman JS (2007) The structural basis of yeast prion strain variants. Nature 449(7159):233-237.
40. Shewmaker F, Kryndushkin D, Chen B, Tycko R, Wickner RB (2009) Two prion variants of Sup35p have in-register parallel β-sheet structures, independent of hydration. Biochemistry 48(23):5074-5082.
41. Shewmaker F, Wickner RB, Tycko R (2006) Amyloid of the prion domain of Sup35p has an in-register parallel β-sheet structure. Proc Natl Acad Sci USA 103(52):19754-19759.
42. Kishimoto A, et al. (2004) beta-Helix is a likely core structure of yeast prion Sup35 amyloid fibers. Biochem Biophys Res Commun 315(3):739-745.
43. Krishnan R, Lindquist SL (2005) Structural insights into a yeast prion illuminate nucleation and strain diversity. Nature 435(7043):765-772.
44. Dong J, Castro CE, Boyce MC, Lang MJ, Lindquist S (2010) Optical trapping with high forces reveals unexpected behaviors of prion fibrils. Nat Struct Mol Biol 17(12):1422-1430.
45. DeSantis ME, Shorter J (2012) Hsp104 drives "protein-only" positive selection of Sup35 prion strains encoding strong [PSI(+)]. Chem Biol 19(11):1400-1410.
46. Toombs JA, McCarty BR, Ross ED (2010) Compositional determinants of prion formation in yeast. Mol Cell Biol 30(1):319-332.
47. Frederick KK, et al. (2014) Distinct prion strains are defined by amyloid core structure and chaperone binding site dynamics. Chem Biol 21(2):295-305.
48. Bateman D, Wickner RB (2013) The [PSI+] prion exists as a dynamic cloud of variants. PLoS Genet 9(1):e1003257.
49. King CY (2001) Supporting the structural basis of prion strains: Induction and identification of [PSI] variants. J Mol Biol 307(5):1247-1260.
50. Chang H-Y, Lin J-Y, Lee H-C, Wang H-L, King C-Y (2008) Strain-specific sequences required for yeast [PSI+] prion propagation. Proc Natl Acad Sci USA 105(36):13345-13350.
51. DePace AH, Santoso A, Hillner P, Weissman JS (1998) A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell 93(7):1241-1252.
52. Tycko R (2007) Symmetry-based constant-time homonuclear dipolar recoupling in solid state NMR. J Chem Phys 126(6):064506.
53. Diaz-Avalos R, King CY, Wall J, Simon M, Caspar DLD (2005) Strain-specific morphologies of yeast prion amyloid fibrils. Proc Natl Acad Sci USA 102(29):10165-10170.
54. Luckgei N, et al. (2013) The conformation of the prion domain of Sup35p in isolation and in the full-length protein. Angew Chem Int Ed Engl 52(48):12741-12744.
55. Schutz AK, et al. (2014) Solid-state NMR sequential assignments of the amyloid core of full-length Sup35p. Biomol NMR Assign 8(2):349-356.
56. Wickner RB, Edskes HK, Shewmaker F, Nakayashiki T (2007) Prions of fungi: Inherited structures and biological roles. Nat Rev Microbiol 5(8):611-618.
57. Sherman F (1991) Getting started with yeast. Guide to Yeast Genetics and Molecular Biology, eds Guthrie C, Fink GR (Academic, San Diego), pp 3-21.
58. Jung G, Masison DC (2001) Guanidine hydrochloride inhibits Hsp104 activity in vivo: A possible explanation for its effect in curing yeast prions. Curr Microbiol 43(1):7-10.
59. Conde J, Fink GR (1976) A mutant of Saccharomyces cerevisiae defective for nuclear fusion. Proc Natl Acad Sci USA 73(10):3651-3655.
60. Pines A, Gibby MG, Waugh JS (1973) Proton-enhanced Nmr of dilute spins in solids. J Chem Phys 59(2):569-590.
61. Bennett AE, Rienstra CM, Auger M, Lakshmi KV, Griffin RG (1995) Heteronuclear decoupling in rotating solids. J Chem Phys 103:6951-6958.
62. Petkova AT, Tycko R (2002) Sensitivity enhancement in structural measurements by solid state NMR through pulsed spin locking. J Magn Reson 155(2):293-299.
63. Sikorski RS, Hieter P (1989) A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122(1):19-27.
64. Wishart DS, Sykes BD, Richards FM (1991) Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J Mol Biol 222(2):311-333.